Kayne Anderson Rudnick Investment Management LLC Decreases Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Kayne Anderson Rudnick Investment Management LLC trimmed its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 9.3% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 1,013,777 shares of the company's stock after selling 103,418 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned about 6.71% of U.S. Physical Therapy worth $89,932,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in U.S. Physical Therapy by 35.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 35,761 shares of the company's stock worth $3,172,000 after buying an additional 9,395 shares in the last quarter. Woodline Partners LP purchased a new stake in U.S. Physical Therapy in the fourth quarter worth approximately $2,229,000. Squarepoint Ops LLC boosted its holdings in U.S. Physical Therapy by 33.4% in the fourth quarter. Squarepoint Ops LLC now owns 10,908 shares of the company's stock worth $968,000 after purchasing an additional 2,730 shares during the last quarter. Two Sigma Advisers LP boosted its holdings in U.S. Physical Therapy by 50.0% in the fourth quarter. Two Sigma Advisers LP now owns 30,900 shares of the company's stock worth $2,741,000 after purchasing an additional 10,300 shares during the last quarter. Finally, Snowden Capital Advisors LLC boosted its holdings in U.S. Physical Therapy by 15.6% in the fourth quarter. Snowden Capital Advisors LLC now owns 5,475 shares of the company's stock worth $486,000 after purchasing an additional 740 shares during the last quarter.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock traded down $1.02 on Wednesday, hitting $75.46. 80,253 shares of the company's stock were exchanged, compared to its average volume of 111,680. The company has a 50-day simple moving average of $71.89 and a 200-day simple moving average of $83.01. The stock has a market capitalization of $1.15 billion, a PE ratio of 80.28, a PEG ratio of 3.54 and a beta of 1.44. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $102.89. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, beating the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The firm had revenue of $183.79 million for the quarter, compared to the consensus estimate of $176.78 million. During the same period last year, the firm earned $0.51 EPS. The company's revenue was up 18.0% on a year-over-year basis. As a group, equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.39%. The ex-dividend date is Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio (DPR) is 82.57%.

Insider Buying and Selling

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the company's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the transaction, the chief operating officer now directly owns 7,168 shares in the company, valued at $588,564.48. This represents a 19.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 2.00% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. JMP Securities restated a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Barrington Research dropped their target price on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. JPMorgan Chase & Co. dropped their target price on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Wednesday, March 19th. Wall Street Zen upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. Finally, William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $109.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.